|
|
|
|
E-DRUG Archives (by date)
November 23, 2002
-
[e-drug] Health organisation warns that kala-azar has returned to South Sudan
- From: "Kirsten Myhr" <kirsten.myhr@relis.ulleval.no>
-
[e-drug] WTO wrestles with access to cheap drugs solution
- From: "Kirsten Myhr" <kirsten.myhr@relis.ulleval.no>
-
[e-drug] Accountability of the pharmaceutical industry
- From: "Kirsten Myhr" <kirsten.myhr@relis.ulleval.no>
-
[e-drug] Comments on Sydney WTO meeting
- From: James Love <james.love@cptech.org>
November 21, 2002
-
[e-drug] Consultation on pharmacogenetics and ethics
- From: "Natalie Bartle" <nbartle@nuffieldfoundation.org>
November 20, 2002
-
[e-drug] Lessons from Malarone donation program
- From: Beverley Snell <bev@burnet.edu.au>
-
[e-drug] Drug for chickens blamed for harder-to-treat food poisoning
-
[e-drug] 10.5 Million Children Vaccinated Against Hepatitis B
- From: e-drug@usa.healthnet.org
November 19, 2002
-
[e-drug] Nefazodone under investigation in the Netherlands
- From: e-drug@usa.healthnet.org
-
[e-drug] More on Roche vs MSF on nelfinavir
- From: ingrid.cox@geneva.msf.org
-
[e-drug] Distance training for junior scientists
- From: "Silvia Jarchow" <sjarchow@zmml.uni-bremen.de>
November 16, 2002
-
[e-drug] Kenya PG programmes in Tropical Medicine and Infectious Diseases
- From: Mary Ojoo <mojoo@gerties.org>
-
[e-drug] The pharmaceutical industry as a medicines provider
- From: "Kirsten Myhr" <kirsten.myhr@relis.ulleval.no>
-
[e-drug] Sigmed experience in Malawi
- From: "R. Verhage" <rverhage@cq-link.sr>
November 15, 2002
-
[e-drug] 25 years of essential medicines
-
[e-drug] WSJ on Roche's expensive ARVs
- From: e-drug@usa.healthnet.org
-
[e-drug] access vacancy in MSF-Holland
- From: joost.van.der.meer@amsterdam.msf.org
-
[e-drug] MSF on Sydney WTO meeting
- From: ingrid.cox@geneva.msf.org
November 14, 2002
-
[e-drug] Washington Post editorial on WTO mini in Sydney
- From: "Ellen 't Hoen" <ethoen@hotmail.com>
-
[e-drug] WSJ on WTO Drugs - Sydney
- From: "Ellen 't Hoen" <ethoen@hotmail.com>
-
[e-drug] IMF and the World Bank
- From: "Dimitri Peffer" <dimitri@cmam.imoz.com>
-
[e-drug] WHO/EDM Technical Briefing
- From: "Dimitri Peffer" <dimitri@cmam.imoz.com>
November 13, 2002
-
[e-drug] B & M Gates foundation and Microsoft
- From: "Trouiller, Patrice" <PTrouiller@chu-grenoble.fr>
-
[e-drug] Open letter to Trade Ministers
- From: James Love <james.love@cptech.org>
-
[e-drug] WHO/EDM Technical Briefing documents
November 11, 2002
-
[e-drug] Messages not received by e-drug
- From: e-drug@usa.healthnet.org
-
[e-drug] Regulatory decisions in a globalised world
- From: "Kirsten Myhr" <kirsten.myhr@relis.ulleval.no>
-
[e-drug] RFI patent legislation
- From: "Despina Samara" <despina.samara@kcl.ac.uk>
November 10, 2002
-
[e-drug] Dipyrone(metamizole) (cont)
- From: "Dr.Pablo Adolfo EDas" <pelias@lanet.com.ar>
-
[e-drug] Dipyrone (metamizole)(cont)
- From: "Dr.L.Offerhaus" <lo@euronet.nl>
-
[e-drug] Review of Pharmacist Services
- From: Libby Roughead <Libby.Roughead@unisa.edu.au>
November 09, 2002
-
[e-drug] EU clamps down on reimportation
- From: "Kirsten Myhr" <kirsten.myhr@relis.ulleval.no>
-
[e-drug] Dipyrone (metamizole) and risk of agranulocytosis
- From: "Kirsten Myhr" <kirsten.myhr@relis.ulleval.no>
November 07, 2002
-
[e-drug] EU parliament on production for export:
- From: James Love <james.love@cptech.org>
-
[e-drug] Analysis of South Africa's NDP process
- From: "Andy Gray" <Graya1@nu.ac.za>
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
- From: "Suleman Khatija\\Natalnbi" <natalnbi@nbi-kzn.org.za>
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
November 06, 2002
-
[e-drug] ICIUM 2004 Preliminary Announcement
- From: John Chalker <Jchalker@msh.org>
-
[e-drug] Pharmacy regulation (cont)
- From: "Kate Kikule" <katkikul@nda.or.ug>
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
- From: "Steve Toovey" <toovey@travelclinic.co.za>
-
[e-drug] Essential drugs missing from market (cont)
- From: Azhar Hussain <azhar@thenetwork.org.pk>
November 05, 2002
-
[e-drug] Pharmacy Regulation (cont)
- From: kahimad@yahoo.co.uk
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
- From: Libby Levison <libby@theplateau.com>
November 04, 2002
-
[e-drug] open MSF letter to Roche on nelfinavir
- From: raffaella.ravinetto@geneva.msf.org
November 03, 2002
-
[e-drug] Short course in pharmacoeconomics and drug selection
- From: David Newby <mddan@cc.newcastle.edu.au>
-
[e-drug] Wholesale and retail markups on essential drugs indeveloping countries (cont)
- From: Joel Lexchin <joel.lexchin@utoronto.ca>
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
- From: Joel Lexchin <joel.lexchin@utoronto.ca>
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
- From: "Steve Toovey" <toovey@travelclinic.co.za>
-
[e-drug] Medicines, society, and industry
- From: e-drug@usa.healthnet.org
-
[e-drug] Essential drugs missing from market (cont)
- From: "eurek" <dhyan@wlink.com.np>
-
[e-drug] Mefloquin for malaria prophylaxis
- From: "Markus Fritz" <m.fritz@medi-info.ch>
November 01, 2002
-
[e-drug] Wholesale and retail markups on essential drugs in developing countries
- From: Libby Levison <libby@theplateau.com>
-
[e-drug] Therapeutics Letter 45: Do Single Stereoisomer Drugs Provide Value?
- From: "Ciprian Jauca" <jauca@ti.ubc.ca>
October 31, 2002
-
[e-drug] Cessation of trading activities at ECHO International Health
- From: "Bonnie Fundafunda" <bfunda@echohealth.org.uk>
-
[e-drug] Pharmacy Regulation (cont)
- From: Pauldspivey@aol.com
Mail converted by MHonArc 2.4.9
|
|